HACKENSACK MERIDIAN HEALTH

🇺🇸United States
Ownership
-
Established
2016-01-01
Employees
-
Market Cap
-
Website
https://www.hackensackmeridianhealth.org/

AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-08-08
Last Posted Date
2020-02-11
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
30
Registration Number
NCT03621722
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

Post-operative Urinary Retention (POUR) Following Thoracic Surgery

First Posted Date
2018-08-01
Last Posted Date
2024-04-19
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
127
Registration Number
NCT03609580
Locations
🇺🇸

Daniel Mansour, Hackensack, New Jersey, United States

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Recruiting
Conditions
First Posted Date
2018-07-13
Last Posted Date
2024-07-03
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
49
Registration Number
NCT03586297
Locations
🇺🇸

Hackensack Meridian Health, Hackensack, New Jersey, United States

🇺🇸

Georgetown University, Washington, District of Columbia, United States

🇺🇸

Yale University - Yale Cancer Center, New Haven, Connecticut, United States

Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes

First Posted Date
2018-05-23
Last Posted Date
2024-02-28
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
50
Registration Number
NCT03534193
Locations
🇺🇸

Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, United States

Central Venous Access Study

Completed
Conditions
First Posted Date
2018-03-29
Last Posted Date
2024-06-10
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
217
Registration Number
NCT03480542
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

First Posted Date
2017-07-28
Last Posted Date
2024-11-18
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
12
Registration Number
NCT03232424
Locations
🇺🇸

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

First Posted Date
2017-05-02
Last Posted Date
2022-10-10
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
10
Registration Number
NCT03136497
Locations
🇺🇸

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

HUMC 1612: Optune NovoTTF-200A System

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2017-04-25
Last Posted Date
2024-11-22
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
7
Registration Number
NCT03128047
Locations
🇺🇸

Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack, New Jersey, United States

🇺🇸

Arnold Palmer Hospital for Children, Orlando, Florida, United States

Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)

Completed
Conditions
First Posted Date
2016-12-05
Last Posted Date
2020-02-11
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
300
Registration Number
NCT02981758
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)

First Posted Date
2016-09-20
Last Posted Date
2023-08-22
Lead Sponsor
Hackensack Meridian Health
Target Recruit Count
12
Registration Number
NCT02906332
Locations
🇺🇸

John Theurer Cancer Center-Hackensack Meridian Health, Hackensack, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath